Key House Hearing Intensifies Debate on 340B’s Future Amid Multiple Major Reform Efforts

Rep. Morgan Griffith (R-VA), chairman of the House Energy and Commerce Oversight and Investigations Subcommittee, speaks at a hearing on June 4, 2024.
A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Minnesota Is Seventh State to Enact 340B Contract Pharmacy Law, State Also Expands Covered Entity Reporting

Minnesota Gov. Tim Walz (D) signed a law to prohibit drugmaker 340B contract pharmacy restrictions in the state.
Minnesota became the 7th state to enact a law to protect distribution of 340B drugs through contract pharmacies when the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New York Unlikely to Move 340B Contract Pharmacy, PBM Protections Bill in 2024, Sponsors Say

New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers' and pharmacy benefit managers' (PBMs) policies against covered entities and N.Y. pharmacies based on their 340B participation.
New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers and pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

In Key Hearing, GOP Lawmakers Raise Concerns About 340B Growth and Hospital Use While Democrats Urge Caution

Sue Veer, president and CEO, Carolina Health Centers, speaks at the House Energy and Commerce Committee's Oversight and Investigations Subcommittee hearing on June 4, 2024.
340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Today’s 340B Congressional Hearing Will Include Multiple 340B Critics, Leading Hospital and Health Center Advocates

Dr. Anthony DiGiorgio, a free-market physician at UCSF who suggested last year that Congress could consider ending the 340B program, is one of four witnesses who will testify at a June 4 Congressional hearing on 340B.
A key House subcommittee oversight hearing today on the 340B program will include a witness who previously said Congress should [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Vertex is First to Offer Contract Pharmacy Policy Exemptions to Several States; GSK Restores Discounts To WV Providers

Drugmaker Vertex implemented 340B contract pharmacy restrictions but exempted the six states with laws prohibiting such policies.
Vertex Pharmaceuticals has become the 33rd drugmaker to place 340B contract pharmacy restrictions, but the new policy exempts all six [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drug Industry Lawsuits Challenge West Virginia’s 340B Contract Pharmacy Access Law

PhRMA and Novartis each challenged West Virginia's new 340B contract pharmacy access law in a federal district court.
An influential drug industry group and a major drugmaker each filed lawsuits challenging West Virginia’s 340B contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

RWC-340B Slams ASAP 340B Bill as ‘Dangerous to Public Health’

Shannon Burger
Shannon Burger, president of RWC-340B,, said the organization “strongly opposes" a new 340B overhaul bill.
A major national 340B provider advocacy group is condemning the newly introduced 340B ACCESS Act, arguing that the proposed overhaul [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

ASAP 340B-Backed Bill Would Override State Laws, Could Hurt Contract Pharmacy Agreements, Critics Warn

U.S. Capitol building at sunrise
Five congressional Democrats signed on as co-sponsors to a bill that would bar drugmaker restrictions on 340B contract pharmacy arrangements.
Some long-time 340B advocates have warned that a new federal bill based on input from an alliance of the drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Asks Federal Court to Block New Maryland 340B Contract Pharmacy Law

Drugmaker Novartis filed suit to block Maryland's recently signed 340B contract pharmacy statute.
Maryland this week became the third state with a 340B contract pharmacy protection law to face a drugmaker lawsuit when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live